Second Systemic Sclerosis World Congress a Success PDF Print E-mail
Tuesday, 13 March 2012 14:09
Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.

After the positive experience of 2010 in Florence, AIM Group International organised the second edition the congress, on behalf of World Scleroderma Foundation, founded by Alexander Klee, grandson of the great painter Paul Klee, who also a suffers from scleroderma, a so-called "rare" disease with very painful and debilitating effects.

To approach the social aspects of the disease, the Congress opened to the patients’ associations (FESCA - Scleroderma Federation of European Associations) and organized a parallel conference with hundreds of patients who had the opportunity to debate on clinical cases, experiences and opinions with experts and prominent international physicians.

With a qualified program consisting of seventy seven lectures, around sixty oral presentations and three hundred posters, the Congress attracted over 1,300 delegates from around the world: in fact, in addition to a prevalent presence from European countries, some hundred American, Asian and African participants contributed to reinforcing the international nature of the meeting.

At the end of the World Congress, the Scleroderma Foundation, chaired by Prof. Marco Matucci Cerinic, AIM Group International were appointed for the organisation of the next Congress, to be held in Paris in 2014.

Source: Agency & Association (2012), "The World Scleroderma Foundation meets in Madrid for the “Systemic Sclerosis World Congress” organised by AIM Group International"; ITCM

 
More articles :

» Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants

Systemic sclerosis is a multisystem, connective tissue disease of unknown aetiology characterized by vascular dysfunction, autoimmunity, and enhanced fibroblast activity resulting in fibrosis of the skin, heart, and lungs, and ultimately internal...

» Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases

Stephen C. Mathai, Laura K. Hummers, Hunter C. Champion, Fredrick M. Wigley, Ari Zaiman, Paul M. Hassoun, and Reda E. GirgisObjective. Pulmonary hypertension (PH) is an important cause of mortality in systemic sclerosis (SSc), where it can be...

» New Formulation of PAH Medication Is Now Available

Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug's maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.The product is...

» Erectile Dysfunction Drug Could Improve Raynaud’s Symptoms Associated with Scleroderma

Adding tadalafil (Cialis®; Adcirca®) to the treatment of people with can improve ’s phenomenon symptoms and heal and prevent hand and finger associated with it, according to research presented this week at the American College of Rheumatology...

» The Pain Perspective in Scleroderma

Systemic sclerosis (scleroderma) is a disease in which inflammatory and fibrotic changes result in overproduction and accumulation of and other extracellular matrix proteins, resulting in intimal vascular damage, fibrosis, and occasionally organ...

» Autoimmune Diseases

The month of March is designated by the (AARDA) as National Autoimmune Diseases Awareness Month. The goal of the month is to educate the public on the risk factors, prevalence and severe lack of awareness surrounding autoimmune diseases. The theme...